Conestoga Capital Advisors, LLC Chembio Diagnostics, Inc. Call Options Transaction History

Conestoga Capital Advisors, LLC

  • $7.22 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email